Doping Control Personnel
Protecting the Right to Participate in Clean Sport

Prohibited List

Image alt tag

The Prohibited List is updated annually.

Since 2004, the World Anti-Doping Agency (WADA) has been responsible for the preparation and publication of the list of substances and methods that are prohibited in sport, known as the Prohibited List.

It is one of five International Standards that identifies substances and methods prohibited in- and out-of-competition, in-competition only, and in particular sports. The substances and methods on the List are classified by different categories (such as steroids, stimulants, or gene doping).

An athlete may be permitted to use a prohibited substance or method for medical reasons, if they obtain a Therapeutic Use Exemption (TUE).

The Prohibited List is updated annually following an extensive consultation process facilitated by WADA. Additional substances or methods may be added to the List at any time during the year but this will only occur after a three month notice period.

A summary of key modifications to the 2017 Prohibited List include:

Substances and Methods Prohibited at All Times

S2. Peptide Hormones, Growth Factors, Related Substances and Mimetics:

• GATA Inhibitors (e.g. K-11706) & Transforming Growth Factor-β (e.g. sotatercept, luspatercept)    have been added in 2017

S3. Beta-2 Agonists:

Salbutamol Inhalers (aka Albuterol or marketed as Ventolin)

• Commonly used to treat asthma. Previously, an inhaled dosage of no greater than 1600 micrograms was permitted over 24 hours. However, it was never the intention that this meant that athletes could inhale 1600 micrograms in one go or over a few hours

• Dosing parameters of inhaled salbutamol have been amended to reflect that athletes are allowed a maximum of 1600 micrograms over 24 hours, but not to exceed 800 micrograms every 12 hours

• Salbutamol inhalers commonly dispense either 100 or 200 micrograms per puff/inhalation, this  relates to an allowance of either 8 or 4 inhalations respectively per 12-hour period

• Dose per inhalation can vary between inhalers, therefore athletes should ask their doctor or check the patient information leaflet which accompanies their prescribed inhaler to establish the dose administered in each inhalation

• If an athlete requires more than 800 micrograms in a 12-hour period they should consult their doctor and contact UKAD to determine if they need to apply for a Therapeutic Use Exemption (TUE)

Salmeterol

• Commonly used to treat asthma

• It is usually administered via inhalation twice a day, in the morning and evening, about 12 hours apart

• Under the 2017 List, the maximum allowable dosage of salmeterol has been defined for the first time as “200 micrograms over 24 hours”. This is consistent with manufacturers’ recommendations

• In previous versions of the List, no dosage was provided and instead athletes were advised that inhaled salmeterol was permitted “in accordance with the manufactures’ recommended therapeutic regimen”

• Dose per inhalation can vary between inhalers, therefore athletes should ask their doctor or check the patient information leaflet which accompanies their prescribed inhaler to establish the dose administered in each inhalation

• If an athlete requires more than 200 micrograms over 24 hours, they should consult their doctor and contact UKAD to determine if they need to apply for a Therapeutic Use Exemption (TUE).

Substances and Methods Prohibited In-Competition Only

S6. Stimulants:

• Lisdexamfetamine is currently prohibited. In 2017 it will be classed as a non-specified stimulant

S7. Narcotics:

• Nicomorphine has been added to the List in 2017

• Nicomorphine is an opioid drug which is used in the treatment of severe pain

• It also converts to morphine following administration. Morphine is already prohibited under section 7 of the List

Prohibited Methods

M1. Manipulation of Blood and Blood Components

• Clarified that supplemental oxygen administered intravenously is prohibited, but administration by inhalation is permitted

Monitoring Programme

The following were added to the 2017 Monitoring Programme to establish patterns of use:

• Codeine

• Concurrent use of multiple beta-2-agonists


The Prohibited List can be found on WADA's website.

 

2017 Prohibited List Summary of Changes for Athletes 

 

2017 Prohibited List Summary of Changes for ASP

2017 Prohibited List Summary of Changes for NGBs